President Donald Trump is preparing to make an announcement on Monday that he described as one of the most significant in the nation’s history, as reported by The Independent Journal Review.
Speaking at a memorial rally for Charlie Kirk in Glendale, Arizona, on Sunday, Trump previewed the upcoming event. “I think you’re going to find it to be amazing,” he said.
“I think we found an answer to autism.”
According to reports from Politico and The Washington Post, Trump will be joined by Health and Human Services Secretary Robert F. Kennedy Jr. and Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, to discuss findings that suggest the use of Tylenol during pregnancy may be linked to autism in children.
The event is scheduled for 4 p.m. Monday.
Tylenol’s parent company, Kenvue, issued a statement disputing the claim. “Acetaminophen does not cause autism,” the company said.
The Washington Post also reported that the announcement is expected to cover leucovorin as a possible treatment option for autism. Leucovorin is a drug commonly prescribed to counteract side effects of certain medications and to address folate (vitamin B9) deficiency.
This Could Be the Most Important Video Gun Owners Watch All Year
Autism spectrum disorder (ASD) is typically identified by challenges in communication, social skills, and repetitive behaviors, according to USA Today.
The spectrum is broad, with some individuals unable to communicate verbally while others live independently and achieve high levels of success.
Data from the Centers for Disease Control and Prevention (CDC) shows the prevalence of autism among U.S. 8-year-olds increased from 0.66 percent in 2000 to 1 in 36 by 2020.
The rise has sparked ongoing debate about contributing factors. While researchers have not identified a single cause, studies point to the influence of genetics, possibly in combination with environmental triggers.
Kennedy, who has described autism as an “epidemic,” has long argued that environmental toxins contribute to the increase. His role in the announcement signals a continuation of the administration’s focus on uncovering environmental and medical links to the disorder.
The Monday announcement is expected to draw significant attention from the medical community, parents, and policymakers as the administration seeks to address one of the most pressing public health questions in the country.
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of LifeZette. Contact us for guidelines on submitting your own commentary.
Read the full article here
